Abstract:Immune-based therapeutic approaches for IBD, including anti-TNF therapy, have shown significant success during the last decade. Nevertheless, many patients are not responsive to these therapies and suffer from severe side effects. Therefore, an increased understanding of the fundamental immune mechanisms controlling gut inflammation is critical for the rational design and development of more effective therapies of IBD. Innate lymphoid cells (ILCs) have recently emerged as key players in regulating the balance between protective immunity and immunopathology at mucosal surfaces. However, the cellular and molecular pathways that control crosstalk between ILCs and intestinal epithelial cells during inflammation remain poorly understood. Our recent study revealed that Lymphotoxin (LT), a member of TNF superfamily of cytokines, produced by RORgt+ ILCs in the gut is critical for protection against the mucosal bacterial pathogen Citrobacter rodentium. In the present study, we aimed to determine how LT signaling controls ILCs to regulate the intestinal inflammation. An acute mouse model of IBD induced by dextran sodium sulfate (DSS) was used. WT and LT-beta receptor (LTbR)-deficient mice were treated with 3.5% DSS in drinking water for 5 days followed by normal water thereafter. Our data show that LTbR signaling is essential for protection and recovery from DSS-induced colitis. LTbR deficient mice failed to upregulate IL-22 in the colon and succumbed rapidly after DSS administration. By using RORgt-GFP reporter mice and cell sorting approach we found the impaired IL-22 production by distinct populations of ILCs in the colon after DSS-induced inflammation. Recent studies indicated a protective role of IL-22 in IBD by enhancing barrier integrity and epithelial innate immunity. We found that reduced IL-22 expression in LTbR-deficient mice was associated with defected mucin genes expression and impaired proliferation of intestinal epithelial cells after DSS-induced injury. Bone marrow transfer experiments revealed that LTbR expression on both bone marrow-derived and radioresistant stromal cells is required for the control of intestinal inflammation. To define which LTbR-expressing cells are essential for protection, we have generated mice with a specific inactivation of LTbR in intestinal epithelial cells, and bone marrow-derived cell populations. These mouse models will help us to further investigate the critical pathways to control intestinal inflammation. Our data indicate that LTbR signaling prevents intestinal inflammation by controlling the IL-22 protection pathway.

IL-22 Bridges the Lymphotoxin Pathway with the Maintenance of Colonic Lymphoid Structures During Infection with Citrobacter Rodentium.

A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic crypts

Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge

Lymphotoxin-dependent Control of Innate Immune Responses in the Gut

Interleukin 22 Expands Transit-Amplifying Cells While Depleting Lgr5+ Stem Cells via Inhibition of Wnt and Notch Signaling

IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence

Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection

The Pathogenic Roles of IL-22 in Colitis: Its Transcription Regulation by Musculin in T Helper Subsets and Innate Lymphoid Cells

Il-22 Deficiency Alters Colonic Microbiota to Be Transmissible and Colitogenic

Deficiency of IL-22-binding protein enhances the ability of the gut microbiota to protect against enteric pathogens.

I don't know about you, but I'm feeling IL-22

Innate lymphoid cells protect host against intestinal pathogen through Id2 dependent IL-22 production and regulation of microbiota. (MUC4P.855)

IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology

IL-22-dependent responses and their role during Citrobacter rodentium infection

Distal colonocytes targeted by C. rodentium recruit T-cell help for barrier defence

IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology

Lymphotoxin-Dependent Control of Intestinal Inflammation

IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB

Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota

Interleukin‐22 and intestinal homeostasis: Protective or destructive?

Role of Interleukin-22 in ulcerative colitis